Fibroblast Growth Factor 21 (FGF21) Administration Sex-Specifically Affects Blood Insulin Levels and Liver Steatosis in Obese <i>A<sup>y</sup></i> Mice
FGF21 is a promising candidate for treating obesity, diabetes, and NAFLD; however, some of its pharmacological effects are sex-specific in mice with the <i>A<sup>y</sup></i> mutation that evokes melanocortin receptor 4 blockade, obesity, and hepatosteatosis. This suggests tha...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-12-01
|
| Series: | Cells |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2073-4409/10/12/3440 |
| _version_ | 1797505987069870080 |
|---|---|
| author | Elena Makarova Antonina Kazantseva Anastasia Dubinina Elena Denisova Tatiana Jakovleva Natalia Balybina Nataliya Bgatova Konstantin Baranov Nadezhda Bazhan |
| author_facet | Elena Makarova Antonina Kazantseva Anastasia Dubinina Elena Denisova Tatiana Jakovleva Natalia Balybina Nataliya Bgatova Konstantin Baranov Nadezhda Bazhan |
| author_sort | Elena Makarova |
| collection | DOAJ |
| description | FGF21 is a promising candidate for treating obesity, diabetes, and NAFLD; however, some of its pharmacological effects are sex-specific in mice with the <i>A<sup>y</sup></i> mutation that evokes melanocortin receptor 4 blockade, obesity, and hepatosteatosis. This suggests that the ability of FGF21 to correct melanocortin obesity may depend on sex. This study compares FGF21 action on food intake, locomotor activity, gene expression, metabolic characteristics, and liver state in obese <i>A<sup>y</sup></i> males and females. <i>A<sup>y</sup></i> mice were administered FGF21 for seven days, and metabolic parameters and gene expression in different tissues were assessed. Placebo-treated females were more obese than males and had lower levels of blood insulin and liver triglycerides, and higher expression of genes for insulin signaling in the liver, white adipose tissue (WAT) and muscles, and pro-inflammatory cytokines in the liver. FGF21 administration did not affect body weight, and increased food intake, locomotor activity, expression of <i>Fgf21</i> and <i>Ucp1</i> in brown fat and genes related to lipolysis and insulin action in WAT regardless of sex; however, it decreased hyperinsulinemia and hepatic lipid accumulation and increased muscle expression of <i>Cpt1</i> and <i>Irs1</i> only in males. Thus, FGF21’s beneficial effects on metabolic disorders associated with melanocortin obesity are more pronounced in males. |
| first_indexed | 2024-03-10T04:26:10Z |
| format | Article |
| id | doaj.art-c9ad57c8caec452bbdf122c7a101288c |
| institution | Directory Open Access Journal |
| issn | 2073-4409 |
| language | English |
| last_indexed | 2024-03-10T04:26:10Z |
| publishDate | 2021-12-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Cells |
| spelling | doaj.art-c9ad57c8caec452bbdf122c7a101288c2023-11-23T07:37:48ZengMDPI AGCells2073-44092021-12-011012344010.3390/cells10123440Fibroblast Growth Factor 21 (FGF21) Administration Sex-Specifically Affects Blood Insulin Levels and Liver Steatosis in Obese <i>A<sup>y</sup></i> MiceElena Makarova0Antonina Kazantseva1Anastasia Dubinina2Elena Denisova3Tatiana Jakovleva4Natalia Balybina5Nataliya Bgatova6Konstantin Baranov7Nadezhda Bazhan8The Laboratory of Physiological Genetics, The Institute of Cytology and Genetics, 630090 Novosibirsk, RussiaThe Laboratory of Physiological Genetics, The Institute of Cytology and Genetics, 630090 Novosibirsk, RussiaThe Laboratory of Physiological Genetics, The Institute of Cytology and Genetics, 630090 Novosibirsk, RussiaThe Laboratory of Physiological Genetics, The Institute of Cytology and Genetics, 630090 Novosibirsk, RussiaThe Laboratory of Physiological Genetics, The Institute of Cytology and Genetics, 630090 Novosibirsk, RussiaThe Laboratory of Physiological Genetics, The Institute of Cytology and Genetics, 630090 Novosibirsk, RussiaThe Laboratory of Physiological Genetics, The Institute of Cytology and Genetics, 630090 Novosibirsk, RussiaThe Institute of Molecular and Cellular Biology, 630090 Novosibirsk, RussiaThe Laboratory of Physiological Genetics, The Institute of Cytology and Genetics, 630090 Novosibirsk, RussiaFGF21 is a promising candidate for treating obesity, diabetes, and NAFLD; however, some of its pharmacological effects are sex-specific in mice with the <i>A<sup>y</sup></i> mutation that evokes melanocortin receptor 4 blockade, obesity, and hepatosteatosis. This suggests that the ability of FGF21 to correct melanocortin obesity may depend on sex. This study compares FGF21 action on food intake, locomotor activity, gene expression, metabolic characteristics, and liver state in obese <i>A<sup>y</sup></i> males and females. <i>A<sup>y</sup></i> mice were administered FGF21 for seven days, and metabolic parameters and gene expression in different tissues were assessed. Placebo-treated females were more obese than males and had lower levels of blood insulin and liver triglycerides, and higher expression of genes for insulin signaling in the liver, white adipose tissue (WAT) and muscles, and pro-inflammatory cytokines in the liver. FGF21 administration did not affect body weight, and increased food intake, locomotor activity, expression of <i>Fgf21</i> and <i>Ucp1</i> in brown fat and genes related to lipolysis and insulin action in WAT regardless of sex; however, it decreased hyperinsulinemia and hepatic lipid accumulation and increased muscle expression of <i>Cpt1</i> and <i>Irs1</i> only in males. Thus, FGF21’s beneficial effects on metabolic disorders associated with melanocortin obesity are more pronounced in males.https://www.mdpi.com/2073-4409/10/12/3440FGF21<i>A<sup>y</sup></i> miceobesityliver steatosissex differencesgene expression |
| spellingShingle | Elena Makarova Antonina Kazantseva Anastasia Dubinina Elena Denisova Tatiana Jakovleva Natalia Balybina Nataliya Bgatova Konstantin Baranov Nadezhda Bazhan Fibroblast Growth Factor 21 (FGF21) Administration Sex-Specifically Affects Blood Insulin Levels and Liver Steatosis in Obese <i>A<sup>y</sup></i> Mice Cells FGF21 <i>A<sup>y</sup></i> mice obesity liver steatosis sex differences gene expression |
| title | Fibroblast Growth Factor 21 (FGF21) Administration Sex-Specifically Affects Blood Insulin Levels and Liver Steatosis in Obese <i>A<sup>y</sup></i> Mice |
| title_full | Fibroblast Growth Factor 21 (FGF21) Administration Sex-Specifically Affects Blood Insulin Levels and Liver Steatosis in Obese <i>A<sup>y</sup></i> Mice |
| title_fullStr | Fibroblast Growth Factor 21 (FGF21) Administration Sex-Specifically Affects Blood Insulin Levels and Liver Steatosis in Obese <i>A<sup>y</sup></i> Mice |
| title_full_unstemmed | Fibroblast Growth Factor 21 (FGF21) Administration Sex-Specifically Affects Blood Insulin Levels and Liver Steatosis in Obese <i>A<sup>y</sup></i> Mice |
| title_short | Fibroblast Growth Factor 21 (FGF21) Administration Sex-Specifically Affects Blood Insulin Levels and Liver Steatosis in Obese <i>A<sup>y</sup></i> Mice |
| title_sort | fibroblast growth factor 21 fgf21 administration sex specifically affects blood insulin levels and liver steatosis in obese i a sup y sup i mice |
| topic | FGF21 <i>A<sup>y</sup></i> mice obesity liver steatosis sex differences gene expression |
| url | https://www.mdpi.com/2073-4409/10/12/3440 |
| work_keys_str_mv | AT elenamakarova fibroblastgrowthfactor21fgf21administrationsexspecificallyaffectsbloodinsulinlevelsandliversteatosisinobeseiasupysupimice AT antoninakazantseva fibroblastgrowthfactor21fgf21administrationsexspecificallyaffectsbloodinsulinlevelsandliversteatosisinobeseiasupysupimice AT anastasiadubinina fibroblastgrowthfactor21fgf21administrationsexspecificallyaffectsbloodinsulinlevelsandliversteatosisinobeseiasupysupimice AT elenadenisova fibroblastgrowthfactor21fgf21administrationsexspecificallyaffectsbloodinsulinlevelsandliversteatosisinobeseiasupysupimice AT tatianajakovleva fibroblastgrowthfactor21fgf21administrationsexspecificallyaffectsbloodinsulinlevelsandliversteatosisinobeseiasupysupimice AT nataliabalybina fibroblastgrowthfactor21fgf21administrationsexspecificallyaffectsbloodinsulinlevelsandliversteatosisinobeseiasupysupimice AT nataliyabgatova fibroblastgrowthfactor21fgf21administrationsexspecificallyaffectsbloodinsulinlevelsandliversteatosisinobeseiasupysupimice AT konstantinbaranov fibroblastgrowthfactor21fgf21administrationsexspecificallyaffectsbloodinsulinlevelsandliversteatosisinobeseiasupysupimice AT nadezhdabazhan fibroblastgrowthfactor21fgf21administrationsexspecificallyaffectsbloodinsulinlevelsandliversteatosisinobeseiasupysupimice |